Status:
COMPLETED
Mometasone Furoate Nasal Spray in Italian Children
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Rhinitis, Allergic
Nasal Allergy
Eligibility:
All Genders
4-12 years
Brief Summary
Objective Seasonal allergic rhinitis (SAR) is a common disease in childhood and characterized by type 2 inflammation, bothersome symptoms, and impaired quality of life (QoL). Intranasal corticosteroid...
Detailed Description
Objective Seasonal allergic rhinitis (SAR) is a common disease in childhood and characterized by type 2 inflammation, bothersome symptoms, and impaired quality of life (QoL). Intranasal corticosteroid...
Eligibility Criteria
Inclusion
- Inclusion criteria were: age range 4-12 years, SAR diagnosis, Total Symptoms Score (TSS) ≥ 6, and written informed consent of both parents or legal guardians.
Exclusion
- Exclusion criteria were: perennial AR, rhinitis due to other causes, concomitant acute or chronic rhinosinusitis, nasal polyps, asthma comorbidity, current use of topical or systemic corticosteroids, antihistamines, antileukotrienes, inadequate washout of them, nasal anatomic defect, respiratory infections in the last two weeks, participation in other clinical studies in the previous month, documented hypersensitivity to the study product or its excipients, and trip planned outside of the study area.
Key Trial Info
Start Date :
June 20 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 20 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT05301647
Start Date
June 20 2019
End Date
October 20 2021
Last Update
March 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Second University
Naples, Italy, 80138